MA28286A1 - Dérivés de 1-N-phenyl-amino-1H-imidazole et compositions pharmaceutiques les contenant - Google Patents

Dérivés de 1-N-phenyl-amino-1H-imidazole et compositions pharmaceutiques les contenant

Info

Publication number
MA28286A1
MA28286A1 MA29173A MA29173A MA28286A1 MA 28286 A1 MA28286 A1 MA 28286A1 MA 29173 A MA29173 A MA 29173A MA 29173 A MA29173 A MA 29173A MA 28286 A1 MA28286 A1 MA 28286A1
Authority
MA
Morocco
Prior art keywords
pharmaceutical compositions
compositions containing
phenylamino
imidazole
derivatives
Prior art date
Application number
MA29173A
Other languages
English (en)
French (fr)
Inventor
Jean Lafay
Benoit Rondot
Paule Bonnet
Thierry Clerc
Jacqueline Shields
Igor Duc
Eric Duranti
Francois Puccio
Christian Blot
Philippe Maillos
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34702365&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA28286(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP03293152A external-priority patent/EP1544195A1/en
Application filed by Theramex filed Critical Theramex
Publication of MA28286A1 publication Critical patent/MA28286A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA29173A 2003-12-15 2006-07-07 Dérivés de 1-N-phenyl-amino-1H-imidazole et compositions pharmaceutiques les contenant MA28286A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03293152A EP1544195A1 (en) 2003-12-15 2003-12-15 1-N-phenyl-amino- 1H-imidazole derivatives and pharmaceutical compositions containing them
EP04292681 2004-11-12

Publications (1)

Publication Number Publication Date
MA28286A1 true MA28286A1 (fr) 2006-11-01

Family

ID=34702365

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29173A MA28286A1 (fr) 2003-12-15 2006-07-07 Dérivés de 1-N-phenyl-amino-1H-imidazole et compositions pharmaceutiques les contenant

Country Status (18)

Country Link
US (1) US8476455B2 (OSRAM)
EP (1) EP1694650A1 (OSRAM)
JP (2) JP4834557B2 (OSRAM)
KR (1) KR20060123186A (OSRAM)
CN (1) CN1890221B (OSRAM)
AR (1) AR047144A1 (OSRAM)
AU (1) AU2004299286B2 (OSRAM)
BR (1) BRPI0417407A (OSRAM)
CA (1) CA2549603A1 (OSRAM)
IL (1) IL176077A0 (OSRAM)
MA (1) MA28286A1 (OSRAM)
MX (1) MXPA06006837A (OSRAM)
NO (1) NO20062710L (OSRAM)
NZ (1) NZ548399A (OSRAM)
OA (1) OA13336A (OSRAM)
RU (1) RU2365586C2 (OSRAM)
TW (1) TW200533668A (OSRAM)
WO (1) WO2005058842A1 (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127923D0 (en) 2001-11-21 2002-01-16 Sterix Ltd Compound
AU2007271486A1 (en) * 2006-07-05 2008-01-10 Merck Patent Gmbh Sulfamate benzothiophene derivatives
JP2010511640A (ja) * 2006-12-04 2010-04-15 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング スルファマトベンゾチオフェン（ｓｕｌｆａｍａｔｏｂｅｎｚｏｔｈｉｏｐｈｅｎｅ）誘導体
US20100204146A1 (en) 2007-09-17 2010-08-12 Preglem S.A. Treatment of Oestrogen Dependant Conditions in Pre-menopausal Women
GB0914767D0 (en) 2009-08-24 2009-09-30 Sterix Ltd Compound
EP3386968B1 (en) 2015-12-09 2025-04-02 The Board of Trustees of the University of Illinois Benzothiophene-based selective estrogen receptor downregulator compounds
AU2018205262A1 (en) 2017-01-06 2019-07-11 G1 Therapeutics, Inc. Combination therapy for the treatment of cancer
WO2018187414A1 (en) * 2017-04-05 2018-10-11 The Regents Of The University Of California Inhibitors of mtor-rictor interactions
WO2019241156A1 (en) * 2018-06-11 2019-12-19 Loma Linda University Methods of delaying and reversing alzheimer's disease progression

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558625A (en) 1968-10-31 1971-01-26 Merck & Co Inc Pyrazinecarboxyaldehydes and method for their preparation
BE757186A (fr) 1969-10-07 1971-04-07 Bayer Ag Nouveaux esters d'acides pyridazino-thiono-phosphoriques et-phosphoniques, leur procede de preparation et leur application comme insecticides et acaricides
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4584302A (en) 1983-09-26 1986-04-22 Mcneilab, Inc. Methods for the treatment of ventricular dysrhythmia and prevention of ventricular fibrillation
US4937250A (en) * 1988-03-07 1990-06-26 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
US5071861A (en) 1986-03-07 1991-12-10 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
DE3811574A1 (de) * 1988-03-31 1989-10-19 Schering Ag N-substituierte imidazole, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
JP2500849B2 (ja) * 1991-09-02 1996-05-29 山之内製薬株式会社 トリアゾリル置換３級アミノ化合物又はその塩
AU665569B2 (en) * 1991-09-02 1996-01-11 Yamanouchi Pharmaceutical Co., Ltd. Triazolylated tertiary amine compound or salt thereof
GB2273704B (en) * 1992-12-16 1997-01-22 Orion Yhtymae Oy Triazolyl diaryl selective aromatase inhibiting compounds
WO1996035688A1 (en) 1995-05-08 1996-11-14 Nippon Chemiphar Co., Ltd. 2,4-thiazolidinedione or oxazolidinedione derivatives and hypoglycemic agent
DE19731328A1 (de) * 1997-07-22 1999-01-28 Hoechst Ag Imidazol-Derivate mit Biphenylsulfonylcyanamid-Seitenkette, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
GB9807779D0 (en) 1998-04-09 1998-06-10 Ciba Geigy Ag Organic compounds
US6248780B1 (en) 1998-10-01 2001-06-19 Duquesne University Of The Holy Ghost Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same
JP4320089B2 (ja) 1999-07-06 2009-08-26 あすか製薬株式会社 フェニルスルファメート誘導体
US6436972B1 (en) 2000-04-10 2002-08-20 Dalhousie University Pyridones and their use as modulators of serine hydrolase enzymes
EP1345914A1 (en) 2000-12-22 2003-09-24 AstraZeneca AB Therapeutic compounds
KR100732581B1 (ko) 2001-02-23 2007-06-27 케이.유.루벤 리서치 앤드 디벨럽먼트 Ｈｉｖ 억제 ｎ-아미노이미다졸 유도체
CN1370533A (zh) 2001-02-27 2002-09-25 中国人民解放军军事医学科学院放射医学研究所 一类新的苯并噻吩类化合物在防治妇女绝经后综合症和其它与雌激素相关疾病中的用途
US7109193B2 (en) * 2001-04-12 2006-09-19 Wyeth Tricyclic diazepines tocolytic oxytocin receptor antagonists
CA2464770C (en) * 2001-11-21 2011-08-16 Sterix Limited Compound
GB0127923D0 (en) 2001-11-21 2002-01-16 Sterix Ltd Compound
JP2004196795A (ja) * 2002-12-16 2004-07-15 Wyeth 外部寄生虫駆除剤としてのｎ−フェニル−３−シクロプロピルピラゾール−４−カルボニトリル
US6737433B1 (en) 2002-12-16 2004-05-18 Laboratoire Theramex 1-N-phenylamino-1H-imidazole derivatives as aromatase inhibitors and pharmaceutical compositions containing them
AP2066A (en) 2003-05-16 2009-11-27 Theramex Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors

Also Published As

Publication number Publication date
JP2011190277A (ja) 2011-09-29
AU2004299286B2 (en) 2011-06-30
JP2007515420A (ja) 2007-06-14
TW200533668A (en) 2005-10-16
KR20060123186A (ko) 2006-12-01
AR047144A1 (es) 2006-01-11
MXPA06006837A (es) 2006-09-04
WO2005058842A1 (en) 2005-06-30
RU2006125417A (ru) 2008-01-27
CA2549603A1 (en) 2005-06-30
NO20062710L (no) 2006-06-30
RU2365586C2 (ru) 2009-08-27
NZ548399A (en) 2011-01-28
CN1890221A (zh) 2007-01-03
CN1890221B (zh) 2014-07-16
JP5209760B2 (ja) 2013-06-12
IL176077A0 (en) 2006-10-05
BRPI0417407A (pt) 2007-04-03
JP4834557B2 (ja) 2011-12-14
AU2004299286A1 (en) 2005-06-30
EP1694650A1 (en) 2006-08-30
US8476455B2 (en) 2013-07-02
US20070112009A1 (en) 2007-05-17
OA13336A (en) 2006-04-13

Similar Documents

Publication Publication Date Title
MEP45308A (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
MA28747B1 (fr) Dérivés de pyridine
MA30717B1 (fr) Derives de pyridin-3-yle en tant qu'agents immunomodulateurs
MA30718B1 (fr) Derives de pyridin-4-yle en tant qu'agents immunomodulateurs.
MA29926B1 (fr) Derives de pyrazine
EA200500342A1 (ru) Гетероциклические замещённые пиперазины для лечения шизофрении
MA30403B1 (fr) Derives d'acides cycloalkylamines et leurs compositions pharmaceutiques
IL135536A0 (en) Ortho-anthranilamide derivatives and pharmaceutical compositions containing the same
MA27428A1 (fr) Derives de pyrimidine et leur utilisation en tant que modulateurs cb2
EA200200708A1 (ru) Производные бензазола и их применение в качестве модуляторов jnk
BR9904998B1 (pt) derivados de hidroxamida do ácido 5-oxo-pirrolidina-2-carboxìlico e composição farmacêutica.
MA30162B1 (fr) Nouveaux derives de pyrrole a cycles fusionnes
SE0302760D0 (sv) New compounds
MA27769A1 (fr) Dérivées de 2-acylamino-4-phenylthiazole, leur préparation et leur application en thérapeutique
PT896533E (pt) Pentafluorobenzenosulfonamidas e analogos
MA27654A1 (fr) DERIVES HEXAHYDROPYRAZINO [1,2-a]-4,7-DIONE SUBSTITUES, METHODE POUR LEUR PRODUCTION ET LEUR UTILISATION EN TANT QUE MEDICAMENTS
TNSN05073A1 (fr) Quinazolinones spirocondensees nouvelles et leur utilisation comme inhibiteurs de phosphodiesterase
WO2005030766A8 (en) Phenyl - carboxamide compounds useful for treating pain
MA27867A1 (fr) Nouveaux derives de 2h-pyridazine-3-one, compositions pharmaceutiques contenant ces derives et procede de preparation de l'ingredient actif.
TR200101978T2 (tr) 3,3-Biarilpiperidin ve 2,2-biarilmorfolin türevleri.
BRPI0409376A (pt) derivados de indeno como agentes farmacêuticos
MX2008002234A (es) Inhibidores de sulfonamida n-biciclico puenteados de gamma secretasa.
MA28286A1 (fr) Dérivés de 1-N-phenyl-amino-1H-imidazole et compositions pharmaceutiques les contenant
TR200200125T2 (tr) Yeni aminotiyazol türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar.
MA27930A1 (fr) Derives de nicotinamide utiles comme inhibiteurs de pde4